-
Protalix BioTherapeutics is an
Israeli pharmaceutical company that
manufactures a plant-based enzyme,
taliglucerase alfa,
which has
received U.S. Food...
-
stepping down in 2015.
Frost was one of the
first and
largest investors in
Protalix BioTherapeutics,
investing $24
million in the
company that
would later...
-
Perion Network Phinergy Plasan PrimeSense –
acquired by
Apple Inc. in 2013
Protalix BioTherapeutics Psagot Investment House RAD Data
Communications Rad Group...
- name
Elelyso among others, is a
biopharmaceutical medication developed by
Protalix and Pfizer.[full
citation needed] The drug, a
recombinant glucocerebrosidase...
- (1837– )
ProMetic Life
Sciences (1994– )
Promomed (2005– )
ProQR (2012– )
Protalix (1993– )
Protein Sciences (subsidiary of Sanofi;
before 2013– ) Protek...
- ISBN 978-94-007-2216-3. Yukhananov, Anna (1 May 2012). "U.S. FDA
approves Pfizer/
Protalix drug for Gaucher".
Chicago Tribune. Reuters.
Retrieved 2 May 2012. [permanent...
- Gali
Weinreb and Koby
Yeshayahou for
Globes May 2, 2012. FDA
approves Protalix Gaucher treatment Archived May 29, 2013, at the
Wayback Machine Carrington...
-
Israeli company,
Protalix, has
developed a
method to
produce therapeutics in
cultured transgenic carrot or
tobacco cells.
Protalix and its partner, Pfizer...
- has also been a
director for the
following companies:
OphthaliX Inc.,
Protalix BioTherapeutics, Can-Fite BioPharma, Ltd,
Simploud and Teva Pharmaceutical...
-
Retrieved 2012-08-13.
Yukhananov A (1 May 2012). "U.S. FDA
approves Pfizer/
Protalix drug for Gaucher".
Chicago Tribune. Reuters.
Retrieved 2 May 2012.[permanent...
